- Home
- GBX vs SRPT Comparison
GBX vs SRPT Comparison
Compare GBX & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBX
- SRPT
- Stock Information
- Founded
- GBX 1974
- SRPT 1980
- Country
- GBX United States
- SRPT United States
- Employees
- GBX N/A
- SRPT N/A
- Industry
- GBX Railroads
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- GBX Industrials
- SRPT Health Care
- Exchange
- GBX Nasdaq
- SRPT Nasdaq
- Market Cap
- GBX 1.4B
- SRPT 1.7B
- IPO Year
- GBX N/A
- SRPT 1997
- Fundamental
- Price
- GBX $47.00
- SRPT $11.93
- Analyst Decision
- GBX Hold
- SRPT Hold
- Analyst Count
- GBX 2
- SRPT 28
- Target Price
- GBX $59.50
- SRPT $48.42
- AVG Volume (30 Days)
- GBX 718.6K
- SRPT 13.9M
- Earning Date
- GBX 07-01-2025
- SRPT 08-06-2025
- Dividend Yield
- GBX 2.72%
- SRPT N/A
- EPS Growth
- GBX 88.14
- SRPT N/A
- EPS
- GBX 7.10
- SRPT N/A
- Revenue
- GBX $3,533,700,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- GBX N/A
- SRPT $19.93
- Revenue Next Year
- GBX N/A
- SRPT N/A
- P/E Ratio
- GBX $6.62
- SRPT N/A
- Revenue Growth
- GBX 0.70
- SRPT 59.15
- 52 Week Low
- GBX $37.77
- SRPT $10.42
- 52 Week High
- GBX $71.06
- SRPT $150.48
- Technical
- Relative Strength Index (RSI)
- GBX 40.70
- SRPT 28.15
- Support Level
- GBX $48.00
- SRPT $10.42
- Resistance Level
- GBX $49.92
- SRPT $14.54
- Average True Range (ATR)
- GBX 1.56
- SRPT 1.90
- MACD
- GBX -0.81
- SRPT 0.13
- Stochastic Oscillator
- GBX 3.77
- SRPT 12.14
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.